Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Hims & Hers Health, Inc. before investing.

In this article, we go over a few key elements for understanding Hims & Hers Health, Inc.’s stock price such as:

• Hims & Hers Health, Inc.’s current stock price and volume
• Why Hims & Hers Health, Inc.’s stock price changed recently
• Upgrades and downgrades for HIMS from analysts
• HIMS’s stock price momentum as measured by its relative strength

About Hims & Hers Health, Inc. (HIMS)

Before we jump into Hims & Hers Health, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Want to learn more about Hims & Hers Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Hims & Hers Health, Inc..

Hims & Hers Health, Inc.’s Stock Price as of Market Close

As of September 09, 2026, 4:00 PM, CST, Hims & Hers Health, Inc.’s stock price was $27.900.

Hims & Hers Health, Inc. is down 0.96% from its previous closing price of $28.170.

During the last market session, Hims & Hers Health, Inc.’s stock traded between $27.270 and $28.280. Currently, there are approximately 231.75 million shares outstanding for Hims & Hers Health, Inc..

Hims & Hers Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Hims & Hers Health, Inc. Stock Price History

Hims & Hers Health, Inc.’s (HIMS) price is currently down 5.68% so far this month.

During the month of September, Hims & Hers Health, Inc.’s stock price has reached a high of $29.870 and a low of $27.270.

Over the last year, Hims & Hers Health, Inc. has hit prices as high as $65.299 and as low as $13.740. Year to date, Hims & Hers Health, Inc.’s stock is down 14.07%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Hims & Hers Health, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 08, 2026, there was 1 analyst who downgraded Hims & Hers Health, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Hims & Hers Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Hims & Hers Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Hims & Hers Health, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Hims & Hers Health, Inc. (HIMS) by visiting AAII Stock Evaluator.

Relative Price Strength of Hims & Hers Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 08, 2026, Hims & Hers Health, Inc. has a weighted four-quarter relative price strength of -12.80%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how Hims & Hers Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Hims & Hers Health, Inc. Stock Price: Bottom Line

As of September 9, 2026, Hims & Hers Health, Inc.’s stock price is $27.900, which is down 0.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Hims & Hers Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.